$2.00
0.168.70%
At close: -
$1.95
-0.05-2.50%
After Hours: Dec 20, 5:51 PM EDT
Comments
Loading...
Immuneering (NASDAQ:IMRX) Stock, Earnings Estimates, EPS, And Revenue
Immuneering reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 28
EPS Estimate
$-0.430
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Immuneering using advanced sorting and filters.
Data brought to you by Benzinga APIs
Immuneering (IMRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-13 | $-0.49 | $-0.55 | 10.9 % |
| Jun 2024 | 2024-08-06 | $-0.47 | $-0.52 | 9.62 % |
| Mar 2024 | 2024-05-07 | $-0.49 | $-0.46 | -6.52 % |
| Dec 2023 | 2024-03-01 | $-0.52 | $-0.47 | -10.6 % |
Immuneering (IMRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2023 | 2023-05-04 | $0 | $10.00K | -100.0 % |
| Dec 2022 | 2023-03-06 | $456.00 | $60.00K | -99.2 % |
| Sep 2022 | 2022-11-10 | $38.38K | $150.00K | -74.4 % |
| Jun 2022 | 2022-08-10 | $94.42K | $180.00K | -47.5 % |
FAQ
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering (IMRX) is scheduled to report earnings on February 28, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Immuneering (NASDAQ:IMRX)?
The Actual EPS was $-0.49, which beat the estimate of $-0.55.
What were Immuneering’s (NASDAQ:IMRX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.